Bioengineering researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a soft, thin, stretchable bioelectronic device that can be implanted into a tadpole embryo’s brain and record electrical activity with no impact on normal tadpole embryo development or behavior. This novel device could help researchers better understand and treat diseases that manifest in early brain development.

Harvard Move Lab makes a wearable robotic device for stroke survivors.
 

Attivare Therapeutics, a Harvard startup out of the Wyss Institute, has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS), Dana-Farber Cancer Institute, and Massachusetts General Hospital. This technology creates an in vivo training ground for the immune system to fight cancer more effectively and prevent infection.

New printing method creates branching vessels in heart tissue that replicate the structure of human vasculature in vitro.